+86 189 1304 2753 product@eynoslifescience.com

Cell volume 189, issue 22 (29 October 2026) carries 26 analysable papers, of which six touch immunology — including the microbiome and virus–host interface. They fall into three groups that do not talk to each other directly, yet share a common theme: context. The same regulator behaves differently under different stimulation; the same class of metabolite pushes CAR-T outcome in opposite directions; the same RNA element stabilises a transcript whether it sits in a virus or in a therapeutic mRNA.

Immunology and immunotherapy

Microbiome: host immunity and tools

Viral RNA: structure and vaccine design

What this changes at the bench

Three practical consequences. First, the activation state of sorted cells is itself an experimental variable — sorting route, resting time and stimulation conditions should be recorded alongside any transcriptional conclusion. Second, opposite directions within one metabolite class mean that "modulate the microbiota to improve CAR-T" is not an executable instruction. Third, RNA stability is modular: engineered elements can be swapped in, which also means that element effects and backbone effects must be separated when reading such data.

This page is the English summary. The full Chinese article carries the per-paper commentary, the metabolite table, the industrialization flow diagram and the reference list with DOIs: read the full article (Chinese). We publish an English edition of every article; where the full text is not translated yet, the summary above carries the numbers and the conclusion.

All findings above are taken from the published abstracts; no information beyond the abstracts has been added. Products mentioned on this site are for research use only.

Questions about this protocol?

Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.